Cargando…
microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review)
Lung cancer remains the leading cause of cancer-related death worldwide for both men and women, and non-small cell lung cancer (NSCLC) accounts for approximately 80% of all cases. Despite improvements in early diagnosis and newly developed therapies, the 5-year survival rate for NSCLC patients remai...
Autores principales: | JIANG, YAN-WEN, CHEN, LIANG-AN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493048/ https://www.ncbi.nlm.nih.gov/pubmed/22307769 http://dx.doi.org/10.3892/mmr.2012.776 |
Ejemplares similares
-
Sequence trademarks in oncogene associated microRNAs
por: Sharma, Sumit, et al.
Publicado: (2011) -
MicroRNAs as a biomarker in lung cancer
por: Canatan, Duran, et al.
Publicado: (2023) -
Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung Cancer
por: Ma, Jie, et al.
Publicado: (2016) -
The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
por: Nairismägi, Maarja-Liisa, et al.
Publicado: (2013) -
Oncogenic MicroRNAs: Key Players in Malignant Transformation
por: Frixa, Tania, et al.
Publicado: (2015)